Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-000606-11Phase 4Completed
Phase 4, open-label trial of melatonin in epilepsy (2 arms), sponsored by Region Östergötland. Primary endpoint: Presence of epileptiform activity. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-000606-11.